About PenCol Specialty Pharmacy
PenCol Specialty Pharmacy is a Healthcare company based in Denver (United States) founded in 2021, and was acquired by Revelation Pharma in January 2022. Provider of drug compounding pharmacy. Its focus areas include Services for Healthcare Providers, BPO, Outsourced Clinical Services and Drug Compounding. Its competitors include Fagron, Revelation Pharma and Pharmedium.
Company details
PenCol Specialty Pharmacy was founded in 2021 and is based in Denver, United States. Operations center on drug compounding within the specialty pharmacy sector. Customized medications are prepared to meet specific patient requirements. Ownership is attributed to Tony E Jones. Services are delivered in the healthcare field, with a geographic emphasis on the local U.S. market. Standard pharmaceutical protocols are followed to ensure compliance and efficacy.
- Headquarters Denver, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website pencolpharmacy.com
- Social Facebook
- Acquired by Revelation Pharma (Jan 2022)
- Investors
- Acquired byRevelation Pharma
(Jan 2022)
Investors in PenCol Specialty Pharmacy
PenCol Specialty Pharmacy has secured backing from 1 investor. Prominent investors backing the company include Revelation Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A network of compounding pharmacies is operated nationwide. | 2020 | revcustomrx.com | Greenwood Village, United States |
Investor details for PenCol Specialty Pharmacy
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PenCol Specialty Pharmacy
1 people are tracked at PenCol Specialty Pharmacy (1 in leadership).
| Name | Role | Group |
|---|---|---|
Tony E Jones | Owner | Leadership |
Complete people profiles for PenCol Specialty Pharmacy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PenCol Specialty Pharmacy
2 dated milestones of PenCol Specialty Pharmacy across 1 years, from founding to its latest funding, stage changes and deals.
- Founded PenCol Specialty Pharmacy is founded.
- Exit Acquired by Revelation Pharma.
Competitors of PenCol Specialty Pharmacy
PenCol Specialty Pharmacy has 3 listed competitors in our database. They include Fagron, Revelation Pharma and Pharmedium.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fagron.com | 1990 | Saint Paul, United States | 3,315 | Drug compounding services are provided by Fagron. | ||
| revcustomrx.com | 2020 | Greenwood Village, United States | A network of compounding pharmacies is operated nationwide. | |||
| pharmedium.com | 2003 | Lake Forest, United States | Drug compounding services are provided to healthcare facilities nationwide. |
Detailed competitors of PenCol Specialty Pharmacy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PenCol Specialty Pharmacy
The website of PenCol Specialty Pharmacy (pencolpharmacy.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 83.1% vs previous month
Websites whose visitors overlap most with PenCol Specialty Pharmacy. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
alpinecompoundingrx.com | alpinecompoundingrx.com | 100% | #6,092,451 | – |
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as PenCol Specialty Pharmacy (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PenCol Specialty Pharmacy
PenCol Specialty Pharmacy was founded in 2021.
PenCol Specialty Pharmacy is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
PenCol Specialty Pharmacy was founded in 2021 and is based in Denver, United States. Operations center on drug compounding within the specialty pharmacy sector. Customized medications are prepared to meet specific patient requirements. Ownership is attributed to Tony E Jones. Services are delivered in the healthcare field, with a geographic emphasis on the local U.S. market. Standard pharmaceutical protocols are followed to ensure compliance and efficacy.
PenCol Specialty Pharmacy's top competitors include Fagron, Pharmedium and Revelation Pharma.
PenCol Specialty Pharmacy has 1 investor. Key investors include Revelation Pharma.
Yes. PenCol Specialty Pharmacy was acquired by Revelation Pharma in January 2022.